MedPath

Oral Health and Wilson's Disease: SOMAWI

Recruiting
Conditions
Wilson Disease
Interventions
Other: Saliva samples
Other: Questionnaire OHIP-14
Other: Thorough dental examination
Registration Number
NCT05444127
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

Patients with Wilson disease have poorer dental and periodontal health and a have lower oral quality of life than control patients. Patients with a neurological form would also more frequently present limitations in the function of the masticatory apparatus. Systemic treatments for Wilson disease are associated with lesions of the oral mucosa. Analysis of copper level in saliva could testify to the effectiveness of copper depletion in treated patients The main objective is to compare the state of dental health between: patients with Wilson disease in the hepatic form and patients with the neurological form, and a population of controls.

Detailed Description

The comparaison between the three groups is based on evaluation criteria wich is CAOD index of caries severity (developed by Klein and Palmer in 1940) counting the number of permanent teeth with caries (evolving to include non-cavitary caries) (C), absent due to caries (A) and filled (O) in an individual. The maximum score is 28 (third molars are not taken into account). The index is obtained from clinical examination and panoramic dental imaging.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Express consent to participate in the study
  • Member of or beneficiary of a social security scheme
  • For cases: Affected by Wilson's disease
  • For controls: Benefiting from a first routine dental consultation with dental panoramic imaging, outside of an emergency context or treatment follow-up/maintenance
Exclusion Criteria
  • Patient benefiting from a legal protection measure

  • Pregnant or breastfeeding women

  • Severe psychiatric disorders with behavioral disorders

  • For cases:

    • hepatic or neurological decompensation
    • liver transplant patient
  • For witnesses:

    • Patient with hepatic or neurological disease
    • Patient taking dietary supplements enriched with copper or zinc or zinc supplementation
    • Patient wearing removable prostheses with zinc-enriched prosthetic adhesives (Fixodent ProPlus®)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CasesSaliva samplespatients with hepatic form of Wilson disease and those with neurological form
CasesThorough dental examinationpatients with hepatic form of Wilson disease and those with neurological form
controlsQuestionnaire OHIP-14control population consulting in routine dental with panoramic dental imaging, outside of an emergency context
CasesQuestionnaire OHIP-14patients with hepatic form of Wilson disease and those with neurological form
controlsThorough dental examinationcontrol population consulting in routine dental with panoramic dental imaging, outside of an emergency context
Primary Outcome Measures
NameTimeMethod
CAOD index of the severity of the caries impairment counting the number of permanent teeth decayed in an individual. The maximum score is 28 (third molars are not taken into account)inclusion visit

The index is obtained from clinical examination and panoramic dental imaging

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Hôpital Charles Foix

🇫🇷

Ivry-sur-Seine, France

Fondation Adolphe de Rothschild

🇫🇷

Paris 19, France

Hopital Charles Foix

🇫🇷

Ivry-sur-Seine, France

© Copyright 2025. All Rights Reserved by MedPath